Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population

Journal of the American Medical Association

Volumn 288, Issue 2, 2002, Pages 216-221

  Pilcher, Christopher D ^a   McPherson, J Todd ^c   Leone, Peter A ^a,d   Smurzynski, Marlene ^b   Owen ODowd, Judy ^d   Peace Brewer, Amy L ^a   Harris, Juanita ^c   Hicks, Charles B ^e   Eron, Joseph J ^a   Fiscus, Susan A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d NORTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACUTE DISEASE; ARTICLE; CLINICAL PROTOCOL; ENZYME IMMUNOASSAY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MASS SCREENING; PATIENT COUNSELING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS INFECTION;

EID: 0037055095     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.2.216     Document Type: Article

References (26)

1. Immune control of HIV-1 after early treatment of acute infection
2. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes
3. Primary HIV infection
4. Sexual transmission during the incubation period of primary HIV infection
5. HIV in body fluids during primary HIV infection
6. Acute HIV infection
7. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence
8. Clinical and epidemiologic features of primary HIV infection
9. Delayed diagnosis of primary HIV infection after presentation to the health care system
10. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
11. The serostatus approach to fighting the HIV epidemic
12. Diagnosis of primary HIV-1 infection
13. The risk of transfusion-transmitted viral infections
14. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure
15. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing
16. Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2
17. Advantage of combined HIV antibody and p24 antigen assays to 3rd-generation HIV assays in the diagnosis of HIV infection
18. Transmission dynamics of HIV
19. Role of the primary infection in epidemics of HIV infection in gay cohorts
20. Estimating transmission probabilities over time in acute HIV infection from biological data
21. Pigtailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection
22. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
23. Heterosexual transmission of human immunodeficiency virus